Trending stocks

K-Bro Linen Inc CAPEX surged on 54.5% in 2015 and Revenue increased on 5.9%

10.03.2016 • About K-Bro Linen Inc ($KBL) • By InTwits

K-Bro Linen Inc reported 2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • K-Bro Linen Inc has high CAPEX intensity: 5 year average CAPEX/Revenue was 11.9%. At the same time it's a lot of higher than industry average of 8.4%.
  • CAPEX is quite volatile: 24.0 in 2015, 15.5 in 2014, 24.9 in 2013, 12.7 in 2012, 2.8 in 2011
  • The company has highly profitable business model: ROIC is at 14.7%
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

K-Bro Linen Inc ($KBL) key annual financial indicators

mln. CAD201120122013201420152015/2014
P&L
Revenue116.9126.3131.2136.4144.55.9%
Gross Profit110.9
EBITDA19.924.523.326.227.02.7%
Net Income7.911.110.312.212.1-1.1%
Balance Sheet
Cash0.00.00.013.70.0-100.0%
Short Term Debt0.00.00.00.00.0
Long Term Debt6.15.819.60.02.3
Cash flow
Capex2.812.724.915.524.054.5%
Ratios
Revenue growth12.3%8.1%3.9%4.0%5.9%
EBITDA growth18.2%22.9%-4.9%12.5%2.7%
Gross Margin94.9%0.0%
EBITDA Margin17.1%19.4%17.8%19.2%18.6%-0.6%
Net Income Margin6.8%8.8%7.9%8.9%8.3%-0.6%
CAPEX, % of revenue2.4%10.0%19.0%11.4%16.6%5.2%
ROIC14.9%20.3%17.2%16.4%14.7%-1.7%
ROE12.6%17.1%14.9%13.5%10.8%-2.7%
Net Debt/EBITDA0.3x0.2x0.8x-0.5x0.1x0.6x

Revenue and profitability


K-Bro Linen Inc's Revenue increased on 5.9% in 2015. Revenue decline was accompanies by EBITDA margin decline. EBITDA Margin dropped on 65.9 pp from 50.0% to -15.9% in FY2015.

Net Income marign decreased slightly on 0.59 pp from 8.9% to 8.3% in 2015.

Capital expenditures (CAPEX) and working capital investments


In 2015 K-Bro Linen Inc had CAPEX/Revenue of 16.6%. The company's CAPEX/Revenue increased on 6.6 pp from 10.0% in 2012 to 16.6% in 2015. For the last three years the average CAPEX/Revenue was 15.7%.K-Bro Linen Inc maintained rich investment policy and has spent a big chunk of EBITDA (89.0%) to CAPEX.

Return on investment


The company operates at good ROIC (14.70%) while ROE is low (10.84%). ROIC decreased slightly on 1.7 pp from 16.4% to 14.7% in 2015. ROE decreased on 2.7 pp from 13.5% to 10.8% in 2015.

Leverage (Debt)


Company's Net Debt / EBITDA is 0.1x and Debt / EBITDA is 0.1x. Net Debt / EBITDA surged on 0.6x from -0.5x to 0.1x in 2015. Debt jumped while cash dropped on 100% in 2015.

Appendix 1: Peers in Consumer, Non-cyclical


Below we provide K-Bro Linen Inc benchmarking against other companies in Consumer, Non-cyclical industry for the last 5 years. We show data for the top-5 companies by key financial metric together with the median value for all the companies in the industry.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
GDI Integrated Facility Services Inc ($GDI)-38.8%-72.9%218,969.1%18.7%
Cardiome Pharma Corp ($COM)-47.6%471.7%566.0%-30.4%
Patient Home Monitoring Corp ($PHM)170.2%1.9%433.0%238.4%
Family Memorials Inc ($FAM)-13.6%54.7%22.9%245.3%
Nobilis Health Corp ($NHC)16.6%45.3%49.0%169.9%
 
Median (86 companies)17.4%9.3%6.7%13.2%11.9%
K-Bro Linen Inc ($KBL)8.1%3.9%4.0%5.9%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Nobilis Health Corp ($NHC)99.8%
Cipher Pharmaceuticals Inc ($CPH)99.5%98.3%92.7%
Heritage Global Inc ($HGP)99.5%95.7%
Ritchie Bros Auctioneers Inc ($RBA)87.9%88.7%88.4%88.0%89.1%
Concordia Healthcare Corp ($CXR)79.4%86.0%
 
Median (75 companies)34.5%37.4%36.1%35.6%35.1%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Cipher Pharmaceuticals Inc ($CPH)-50.0%40.6%71.4%63.7%12.8%
Merus Labs International Inc ($MSL)32.9%64.7%46.2%61.5%
Valeant Pharmaceuticals International Inc ($VRX)37.0%30.6%27.8%45.6%
EnerCare Inc ($ECI)59.0%52.8%51.0%45.5%39.3%
Information Services Corp ($ISV)34.1%39.6%39.6%37.6%
 
Median (85 companies)7.7%7.4%8.7%10.6%10.3%
K-Bro Linen Inc ($KBL)17.1%19.4%17.8%19.2%18.6%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Neptune Technologies & Bioressources Inc ($NTB)6.0%4.7%73.6%84.6%119.0%
CanaDream Corp ($CDN)68.6%43.3%38.1%70.4%63.4%
Ceapro Inc ($CZO)2.2%3.9%35.3%52.0%
Feronia Inc/Canada ($FRN)129.0%191.4%117.4%42.4%
Microbix Biosystems Inc ($MBX)1.0%1.2%3.0%40.3%38.7%
 
Median (86 companies)2.4%2.6%2.4%2.5%2.2%
K-Bro Linen Inc ($KBL)2.4%10.0%19.0%11.4%16.6%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Biosyent Inc ($RX)45.5%71.7%62.4%62.9%48.2%
Information Services Corp ($ISV)56.0%71.8%72.8%58.9%
Covalon Technologies Ltd ($COV)-49.6%-75.8%-30.1%50.6%-12.4%
Cipher Pharmaceuticals Inc ($CPH)-22.9%21.8%81.4%44.6%-0.1%
Ceapro Inc ($CZO)69.9%-33.5%15.5%43.5%
 
Median (86 companies)7.4%6.3%6.7%6.7%6.5%
K-Bro Linen Inc ($KBL)14.9%20.3%17.2%16.4%14.7%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Noble Iron Inc ($NIR)25.5x12.9x227.3x
Family Memorials Inc ($FAM)15.2x
Amica Mature Lifestyles Inc ($ACC)11.7x9.4x14.7x13.8x12.3x
Cott Corp ($BCB)2.6x2.0x2.2x13.4x4.9x
CRH Medical Corp ($CRH)-2.3x-3.1x-3.5x12.0x1.3x
 
Median (70 companies)1.9x2.8x2.2x2.7x1.8x
K-Bro Linen Inc ($KBL)0.3x0.2x0.8x-0.5x0.1x